These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38271697)

  • 1. Enrichment reveals extensive integration of hepatitis B virus DNA in hepatitis delta-infected patients.
    Ringlander J; Strömberg LG; Stenbäck JB; Andersson ME; Abrahamsson S; Skoglund C; Castedal M; Larsson SB; Rydell GE; Lindh M
    J Infect Dis; 2024 Jan; ():. PubMed ID: 38271697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep sequencing of liver explant transcriptomes reveals extensive expression from integrated hepatitis B virus DNA.
    Ringlander J; Skoglund C; Prakash K; Andersson ME; Larsson SB; Tang KW; Rydell GE; Abrahamsson S; Castedal M; Norder H; Hellstrand K; Lindh M
    J Viral Hepat; 2020 Nov; 27(11):1162-1170. PubMed ID: 32592629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized mice.
    Lempp FA; Volz T; Cameroni E; Benigni F; Zhou J; Rosen LE; Noack J; Zatta F; Kaiser H; Bianchi S; Lombardo G; Jaconi S; Vincenzetti L; Imam H; Soriaga LB; Passini N; Belnap DM; Schulze A; Lütgehetmann M; Telenti A; Cathcart AL; Snell G; Purcell LA; Hebner CM; Urban S; Dandri M; Corti D; Schmid MA
    J Hepatol; 2023 Nov; 79(5):1129-1138. PubMed ID: 37459920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B surface antigen levels and sequences of natural hepatitis B virus variants influence the assembly and secretion of hepatitis d virus.
    Shih HH; Jeng KS; Syu WJ; Huang YH; Su CW; Peng WL; Sheen IJ; Wu JC
    J Virol; 2008 Mar; 82(5):2250-64. PubMed ID: 18094179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infection.
    Giersch K; Helbig M; Volz T; Allweiss L; Mancke LV; Lohse AW; Polywka S; Pollok JM; Petersen J; Taylor J; Dandri M; Lütgehetmann M
    J Hepatol; 2014 Mar; 60(3):538-44. PubMed ID: 24280293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signature of chronic hepatitis B virus infection in nails and hair.
    Komatsu H; Inui A; Odmaa E; Ito Y; Hoshino H; Umetsu S; Tsunoda T; Fujisawa T
    BMC Infect Dis; 2022 May; 22(1):431. PubMed ID: 35509029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis.
    Zachou K; Yurdaydin C; Drebber U; Dalekos GN; Erhardt A; Cakaloglu Y; Degertekin H; Gurel S; Zeuzem S; Bozkaya H; Schlaphoff V; Dienes HP; Bock TC; Manns MP; Wedemeyer H;
    Liver Int; 2010 Mar; 30(3):430-7. PubMed ID: 19840253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring.
    Manesis EK; Schina M; Le Gal F; Agelopoulou O; Papaioannou C; Kalligeros C; Arseniou V; Manolakopoulos S; Hadziyannis ES; Gault E; Koskinas J; Papatheodoridis G; Archimandritis AJ
    Antivir Ther; 2007; 12(3):381-8. PubMed ID: 17591028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Long-Read Sequencing Reveals Comprehensive Architecture, Burden, and Transcriptional Signatures from Hepatitis B Virus-Associated Integrations and Translocations in Hepatocellular Carcinoma Cell Lines.
    Ramirez R; van Buuren N; Gamelin L; Soulette C; May L; Han D; Yu M; Choy R; Cheng G; Bhardwaj N; Chiu J; Muench RC; Delaney WE; Mo H; Feierbach B; Li L
    J Virol; 2021 Sep; 95(19):e0029921. PubMed ID: 34287049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses.
    Pollicino T; Raffa G; Santantonio T; Gaeta GB; Iannello G; Alibrandi A; Squadrito G; Cacciola I; Calvi C; Colucci G; Levrero M; Raimondo G
    J Virol; 2011 Jan; 85(1):432-9. PubMed ID: 20962099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection.
    Franchello A; Ghisetti V; Marzano A; Romagnoli R; Salizzoni M
    Liver Transpl; 2005 Aug; 11(8):922-8. PubMed ID: 16035057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139-Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Anderson M; Gersch J; Holzmayer V; Elsner C; Krawczyk A; Kuhns MC; Cloherty G; Dittmer U; Vaillant A
    Hepatol Commun; 2021 Feb; 5(2):189-202. PubMed ID: 33553968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HBsAg isoform dynamics during NAP-based therapy of HBeAg-negative chronic HBV and HBV/HDV infection.
    Bazinet M; Anderson M; Pântea V; Placinta G; Moscalu I; Cebotarescu V; Cojuhari L; Jimbei P; Iarovoi L; Smesnoi V; Musteata T; Jucov A; Dittmer U; Gersch J; Holzmayer V; Kuhns M; Cloherty G; Vaillant A
    Hepatol Commun; 2022 Aug; 6(8):1870-1880. PubMed ID: 35368148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver biopsy of chronic hepatitis B patients indicates HBV integration profile may complicate the endpoint and effect of entecavir treatment.
    Zhang M; Zhang H; Cheng X; Wang X; Xu H; Gao X; Wu R; Zhang D; Xia Y; Niu J
    Antiviral Res; 2022 Aug; 204():105363. PubMed ID: 35709897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low seroprevalence of hepatitis delta virus co-infection in hepatitis B virus-infected blood donors in China: A multicenter study.
    Chang L; Yan Y; Ji H; Sun H; Jiang X; Lu Z; Wang L; Group HBDS
    Front Microbiol; 2022; 13():992817. PubMed ID: 36452933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Envelope proteins derived from naturally integrated hepatitis B virus DNA support assembly and release of infectious hepatitis delta virus particles.
    Freitas N; Cunha C; Menne S; Gudima SO
    J Virol; 2014 May; 88(10):5742-54. PubMed ID: 24623409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strain-specific responsiveness of hepatitis D virus to interferon-alpha treatment.
    Giersch K; Perez-Gonzalez P; Hendricks L; Goldmann N; Kolbe J; Hermanussen L; Bockmann JH; Volz T; Volmari A; Allweiss L; Petersen J; Glebe D; Lütgehetmann M; Dandri M
    JHEP Rep; 2023 Apr; 5(4):100673. PubMed ID: 36908749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-expression of markers for hepatitis delta and hepatitis B viruses in human liver.
    Ryley NG; Heryet AR; Goldin R; Monjardino J; Saldanha J; Fleming KA
    Histopathology; 1992 Apr; 20(4):331-7. PubMed ID: 1577410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Among Patients with Undetectable Hepatitis B Surface Antigen and Hepatocellular Carcinoma, a High Proportion Has Integration of HBV DNA into Hepatocyte DNA and No Cirrhosis.
    Wong DK; Cheng SCY; Mak LL; To EW; Lo RC; Cheung TT; Seto WK; Fung J; Man K; Lai CL; Yuen MF
    Clin Gastroenterol Hepatol; 2020 Feb; 18(2):449-456. PubMed ID: 31252193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.